Orthofix Medical (OFIX) director granted 14,965 deferred stock units as equity award

Rhea-AI Filing Summary

HENNEMAN JOHN B III reported acquisition or exercise transactions in this Form 4 filing.

Orthofix Medical Inc. director John B. Henneman III received an equity award of 14,965 deferred stock units on common stock. The units were granted at no cash cost and vest in full on the first anniversary of the grant date, contingent on continued board service.

Each deferred stock unit represents a right to receive one share of Orthofix common stock, which will be delivered within 45 days after his service with the company ends. Following this award, Henneman holds 105,774 shares and units directly, including 48,347 deferred stock units that were previously reported.

Insights

Equity Compensation Analyst

Director received routine deferred stock unit grant as board compensation.

The filing shows Orthofix Medical director John B. Henneman III acquired 14,965 deferred stock units as a compensation award, with no cash paid per share. This is a standard non-cash equity grant rather than an open-market purchase or sale.

The units vest in one year, subject to continued service, and settle into common stock within 45 days after his service ends. After this grant, he directly holds 105,774 shares and units, including 48,347 previously reported deferred stock units, suggesting the transaction is routine relative to his overall position.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider HENNEMAN JOHN B III

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,965	$0.00	--

Holdings After Transaction: Common Stock — 105,774 shares (Direct, null)

Footnotes (1)

1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer. Includes 48,347 previously reported deferred stock units.

Key Figures

Deferred stock units granted: 14,965 units Grant price per unit: $0.00 per unit Total holdings after grant: 105,774 shares/units +3 more

6 metrics

Deferred stock units granted 14,965 units Award of deferred stock units on common stock

Grant price per unit $0.00 per unit Reported transaction price per share

Total holdings after grant 105,774 shares/units Direct holdings following transaction

Previously reported deferred units 48,347 units Deferred stock units included in total holdings

Vesting period 1 year Vest in full on first anniversary of grant date

Settlement window after service 45 days Conversion to common stock after termination of service

Key Terms

deferred stock units, vest, termination of service

3 terms

deferred stock units financial

"Represents an award of deferred stock units that vest in full on the first anniversary of the grant date"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

vest financial

"deferred stock units that vest in full on the first anniversary of the grant date"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

termination of service financial

"Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HENNEMAN JOHN B III

(Last) (First) (Middle)

3451 PLANO PARKWAY

(Street)

LEWISVILLE TEXAS 75056

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Orthofix Medical Inc. [ OFIX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/10/2026		A		14,965(1)	A	$0	105,774(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of deferred stock units that vest in full on the first anniversary of the grant date, subject to the reporting person's service through such date. Each deferred stock unit represents a contingent right to receive one share of common stock of the issuer. Vested deferred stock units will settle and convert into common stock within 45 days of the reporting person's termination of service with the issuer.

2. Includes 48,347 previously reported deferred stock units.

	/s/ J. Andres Cedron, attorney-in-fact	06/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Orthofix Medical (OFIX) director John B. Henneman III receive in this Form 4 filing?

He received an award of 14,965 deferred stock units tied to Orthofix Medical common stock. These units are part of his director compensation and were granted at no cash cost per share, increasing his total direct holdings reported in the filing.

How and when do the new deferred stock units for Orthofix Medical (OFIX) vest?

The 14,965 deferred stock units vest in full on the first anniversary of the grant date. Vesting is conditional on Henneman’s continued service with Orthofix Medical through that date, reflecting a standard board retention incentive structure using equity rather than cash.

When will Orthofix Medical (OFIX) deliver shares for John Henneman’s deferred stock units?

Once vested, the deferred stock units convert into Orthofix common shares within 45 days after Henneman’s termination of service. This structure delays share delivery until he leaves the board, aligning equity settlement with the end of his service period.

How many Orthofix Medical (OFIX) shares and units does John Henneman hold after this grant?

After the 14,965-unit award, Henneman directly holds 105,774 shares and deferred stock units in total. This figure includes 48,347 deferred stock units that were previously reported, indicating the new grant is incremental to an existing equity-based position.

Is the Orthofix Medical (OFIX) Form 4 transaction an open-market buy or sell?

No, the Form 4 reflects a grant of 14,965 deferred stock units as compensation, not an open-market trade. The transaction code is “A,” indicating an award or other acquisition, with a reported price per unit of zero dollars in the filing.